Protagonist Therapeutics grants new hires options for 7,300 shares, RSUs for 1,975 shares at $136.64 strike price

• Protagonist Therapeutics granted inducement equity awards on July 31, 2026 to two newly hired employees.
• Awards total options for 7,300 shares, RSUs for 1,975 shares under its amended inducement plan.
• Options carry a $136.64 exercise price, matching the Nasdaq closing price on July 31.
• Options vest over four years: 25% after one year, remainder monthly over three years; RSUs vest 25% annually over four years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608041605ACCESSWRNAPR_____1201426) on August 04, 2026, and is solely responsible for the information contained therein.